Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03976245 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Advanced Therapeutics in Rheumatoid Arthritis (RA)

StatusRecruiting
PhasePhase 4
Started2020-03-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 29, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2024-11-26
Study Status v5
Re-verified, no change to tracked fields
2023-10-03
Study Status, Eligibility, Contacts/Locations v4
Primary completion date2023-03→2025-03
Completion date2023-03→2025-03
Eligibility criteria+10 characters
[...] o etanercept or tofacitinib active serious infection active TBTuberculosis multiple sclerosis current cancer lymphoma ever previous us [...]
2022-05-10
Study Status v3
Primary completion date2020-09→2023-03
Completion date2021-09→2023-03
Start dateestimated 2020-03→confirmed 2020-03-01
2020-02-24
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start date2019-09→2020-03
Study sitesdetails revised at 1 of 1 site
2019-07-11
Study Identification, Study Status, Outcome Measures v1
Secondary endpointsdetails revised at 1 of 1 entry
Study title-22 characters
A Randomized Trial of Advanced Therapeutics in Rheumatoid Arthritis (RA)
2019-06-03
Original filing
This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).
Trial Details
NCT Number NCT03976245
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Academic Medical Organization of Southwestern Ontario
Conditions Rheumatoid Arthritis
Enrollment 144 participants
Start Date 2020-03-01
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-11-29